Carestream Health Announces Distribution Agreement with DMS Group in France

Carestream HealthCarestream Health in France has signed a distribution agreement with Apelem, a subsidiary of the DMS Group in France. Under the terms of the agreement, Carestream can sell two new Platinum remote controlled radiographic tables developed by Apelem exclusively to customers in France and Belgium.

"We are extremely proud that Carestream Health, a world leader in the medical imaging field, should show interest in our new remote controlled radiographic table solution. This distribution contract is testament to the technological excellence of the Platinum table and confirms its major potential in the radiography market," said Jean-Paul Ansel, Managing Director of DMS. "Given the commercial power of Carestream Health, we believe that this agreement will represent a major component of growth for the next several years."

Distribution of the new Platinum dRF model with a fixed detector and the Platinum model with mobile detector and wireless functionality will complement the CARESTREAM DRX-1 family of highly productive capture systems for digital radiography. Founded on the wireless, cassette-size CARESTREAM DRX-1 detector, this portfolio currently includes the DRX-1 System that can convert analogue X-ray rooms to DR technology in less than one day; the DRX-Mobile Retrofit kit to upgrade mobile X-ray systems to wireless DRX-1 technology and a fully automated DRX-Evolution suite that offers virtually unlimited patient positioning.

"The agreement reached with DMS will enable us to offer a complete range of medical imaging systems to our French and Belgian customers”, said Anton Graule, European Sales & Business Development Manager, Medical Imaging Solutions, Carestream Health. "We have been particularly impressed by the technical capabilities of the Platinum radiographic table, as well as by its design and the diagnostic aids developed by DMS which make this table unique in its market."

Related news articles:

About Diagnostic Medical Systems
Specialising in high technology medical diagnostic solutions, Groupe DMS currently ranks number one in France in the development, design and manufacture of dedicated digital and conventional imagery radiology systems as well as bone mineral density testing. The Group's strategy, principally based on technological innovation, enables it to offer a complete range of medical imaging systems. Its representation on all continents, thanks to a network of 80 national distributors, subsidiaries and joint venture partners brings, for Groupe DMS, an international dimension to the quality of its products. DMS products are aimed at hospitals, clinics, radiologists and specialist medical practitioners who use diagnostic tools (rheumatoid and orthopaedic practitioners, gynaecologists etc). DMS has a listing in section C of the Euronext Paris market of NYSE Euronext - Code ISIN : FR 0000063224 - Mnemonic Code: DGM
DMS Contact: Nicolas BOUCHEZ, 0033 (0)1 77 35 04 37

About Carestream Health
Carestream Health is a world supplier of medical and dental imaging systems and medical computer solutions; molecular imaging systems for life science research and drug development; radiographic films and digital systems for the non-destructive testing market. For more information on the wide range of products, solutions and services, please contact your Carestream Health representative or visit the web site: www.carestreamhealth.com.

CARESTREAM is a trade mark of Carestream Health

Most Popular Now

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...